Efficacy and safety of sacubitril-valsartan in Maintenance Hemodialysis patients with hypertension:A retrospective study
In MHD patients with hypertension, SV demonstrates a preliminary ability to lower blood pressure and appears safe. Further prospective randomized studies are warranted to validate our findings.
Authors
- Jurong Yang (ORCID: https://orcid.org/0000-0002-6792-4617)
- Shaofa Wu (ORCID: https://orcid.org/0009-0002-0394-902X)
- Xin Ran (ORCID: https://orcid.org/0000-0001-8833-9006)
- Bin Yang (ORCID: https://orcid.org/0000-0001-5315-9240)
- Ying Ran
- Haifeng Ding (ORCID: https://orcid.org/0000-0001-7524-0779)
- Pan Li (ORCID: https://orcid.org/0000-0003-2682-7500)
- Ran Jing (ORCID: https://orcid.org/0000-0002-3037-8982)
- Yu Zhu (ORCID: https://orcid.org/0000-0002-4411-0880)
- Lili Jiang (ORCID: https://orcid.org/0000-0002-8466-591X)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1371/journal.pone.0330038
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00